Best of ASTRO Gulf 2024: Advancing Oncology in the Gulf

Best of ASTRO Gulf 2024 brought together radiation oncologists, medical oncologists, surgeons, physicists, technologists, and allied health professionals from across the Gulf and beyond to review and contextualize the most important findings from ASTRO 2023. Delivered in a hybrid format, the meeting combined in-person networking and hands-on learning with broad virtual participation, creating an accessible, high-impact educational experience for oncology teams in the region.

Hybrid Format and Participation

The conference used a fully hybrid model, with parallel in-person and virtual components:

• In-person component: Enabled face-to-face networking, hands-on workshops, and direct engagement with industry exhibits.
• Virtual access: Allowed regional and international participants, including those from remote or resource-limited settings, to follow the full scientific program and join live discussions.

This approach helped democratize access to world-class oncology education, reflected in event metrics of more than 300 attendees and over 40 expert speakers from across the Gulf region and internationally.

Agenda and Scientific Themes

The two-day agenda combined thematic scientific sessions, keynote lectures, panel discussions, industry symposia, and interactive workshops. Content was curated to mirror the breadth and depth of ASTRO 2023 while highlighting Gulf-specific practice needs, infrastructure realities, and innovation priorities.

Comprehensive Cancer Site Coverage

Disease-site tracks ensured relevance to the full spectrum of oncology practice in the Gulf. Major cancer types and topics covered included:

• Breast cancer
• Gastrointestinal (GI) cancers
• Gynecological cancers
• Genitourinary (GU) cancers
• Lung cancer
• Head and neck cancers
• Central nervous system (CNS) tumors
• Sarcoma, cutaneous tumors, and pediatric cancers
• Hematologic malignancies
• Palliative care and supportive oncology

Each session highlighted pivotal clinical trials, translational research, and guideline updates, followed by panel discussions that translated data into Gulf-specific practice recommendations.

Integration of ASTRO 2023 Highlights

A core objective was to deliver the most practice-changing and methodologically robust studies from ASTRO 2023 to a Gulf audience. Faculty selected key abstracts and guideline updates for their direct implications in areas such as hypofractionation, stereotactic body radiotherapy (SBRT), adaptive radiotherapy, and integration of systemic therapy with radiation.

Radiogenomics and Precision Oncology

Radiogenomics—linking genomic information to radiation response—was a central theme, reflecting the region's growing investment in precision medicine. Dedicated sessions explored:

• Use of genomic signatures to predict radiosensitivity, toxicity risk, and patterns of failure.
• Integration of radiogenomic biomarkers into daily clinical decision-making and treatment planning.
• Emerging evidence on the role of the microbiome and immunogenomics in modulating radiotherapy outcomes in GI and other cancers.

Presentations on genomic biosignatures in breast cancer, immunogenomic profiling in prostate cancer, and microbiome studies in rectal cancer demonstrated how bench research is now informing real-world protocols and guideline development.

Workshops, Interactive Learning, and Technology

Hands-on workshops and interactive case sessions were interwoven throughout the program to reinforce application of new evidence in daily practice. Topics included:

• Advanced radiotherapy planning, quality assurance, and peer review.
• Multidisciplinary management of complex and rare cases across disease sites.
• Implementation pathways for new technologies, protocols, and hypofractionated regimens.

The industry exhibition showcased next-generation technologies such as surface guided radiation therapy (SGRT), intraoperative radiotherapy devices, and advanced imaging and planning platforms from leading vendors. Industry symposia covered HER2+ metastatic breast cancer, cranial radiosurgery, and multimodality treatment for lung cancer, providing a bridge between innovation and bedside practice.

International and Regional Faculty

The meeting featured a balanced mix of international experts and regional leaders from the USA, Canada, Europe, the Middle East, and North Africa. International faculty presented long-term outcomes from randomized trials in brain metastases, breast and prostate cancer, CNS tumors, and sarcomas, while regional speakers focused on real-world implementation, Gulf epidemiology, and health-system constraints.

Leaders from UAE, Saudi Arabia, Egypt, Jordan, and other Gulf states chaired sessions, moderated panels, and led scientific planning—underscoring the region’s growing ownership of oncology agenda-setting and guideline adaptation.

Disease-Site Highlights

Several tracks stood out for their potential to shift practice across the Gulf:

• Gastrointestinal cancers: Data on neoadjuvant strategies in esophago-gastric cancers, watch-and-wait approaches in rectal cancer, and microbiome–immunogenomic interactions pointed toward more biology-driven, organ-preserving care.
• Sarcoma and cutaneous tumors: Meta-analyses of hypofractionated preoperative radiotherapy and dose-painting techniques supported individualized treatment of rare, complex tumors, including pediatric sarcomas.
• CNS tumors: Updated target-volume delineation guidelines, stereotactic radiosurgery trials, and early work in AI-assisted planning highlighted rapid advances in neuro-oncology.
• Breast cancer: Trials on partial vs whole-breast irradiation, SABR for oligoprogression, and genomic signatures for DCIS reinforced trends toward de-escalation, precision, and incorporation of patient-reported outcomes.
• GU and lung cancers: Long-term outcomes from SBRT vs conventional radiotherapy, immunogenomic profiling, and combined SBRT–immunotherapy strategies illustrated the move toward biomarker-guided, multimodality care.
• Head and neck, hematologic malignancies, and palliative care: Talks on HPV ctDNA, consolidative radiotherapy post–CAR T-cell therapy, and innovative SABR-based palliative approaches broadened the scope of radiation oncology to survivorship and supportive care.

Regional Collaboration and Capacity Building

Best of ASTRO Gulf 2024 served as a catalyst for Gulf-wide collaboration. Parallel meetings, including a Gulf Oncology Society gathering, focused on nurturing young leaders, planning future conferences, and developing regionally adapted guidelines. Discussions emphasized building biobanks, launching collaborative trials, and sharing data across institutions to accelerate radiogenomics and precision-oncology research.

Participants also confronted challenges such as resource disparities and workforce shortages, but emphasized volunteerism, mentorship, and inter-institutional networking as practical levers for progress.

Clinical Impact, CME, and Policy Implications

The conference placed strong emphasis on translating evidence into everyday clinical decisions. Case-based discussions, guideline-focused sessions, and quality-assurance workshops helped participants integrate hypofractionated regimens, immunotherapy–radiotherapy combinations, and advanced imaging and planning tools into their workflows. The meeting was CME-accredited, reinforcing its role in professional development.

Broader policy themes included adapting international guidelines to Gulf populations, strengthening radiation oncology workforce capacity, and ensuring equitable access to advanced technologies and clinical trials across the region.

Conclusion

Best of ASTRO Gulf 2024 stands out as a transformative milestone for oncology in the Gulf. By integrating state-of-the-art science from ASTRO 2023, showcasing next-generation technologies, and nurturing a culture of collaboration and precision oncology, the event set a new benchmark for regional cancer conferences. Its hybrid design, radiogenomics focus, and emphasis on patient-centered outcomes are likely to shape clinical practice, research priorities, and education agendas across the Gulf for years to come.